Literature DB >> 7463305

Quantitative structure-activity relationships between hydroxamic acids and their urease inhibitory potency.

K Munakata, K Kobashi, J Hase.   

Abstract

Quantitative structure activity relationships between physico-chemical properties of four series of more than sixty hydroxamic acids [R-(CONHCH2)n-CONHOH, R=aromatic or aliphatic, n=1 or 0) and their urease inhibitory activities were examined. The best improved regression equation primarily indicated that the inhibitory activities of hydroxamic acids were parabolically varied with the hydrophobic variable, pi of the R moiety and the optimal pi value was calculated to be 2.58. Furthermore, the inhibitory activities of congeners were found to be significantly affected by the B1 variable representing the minimum width of steric size of the R moiety. Besides, it was clarified by using two indicator variables that inhibitory activities were not affected by the R moiety, whether aromatic or aliphatic, but positively affected by the presence of the -CONHCH2-group between the R moiety and the hydroxamic acid group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7463305     DOI: 10.1248/bpb1978.3.457

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  3 in total

1.  Molecular modeling studies on the urease active site and the enzyme-catalyzed urea hydrolysis.

Authors:  R Medina; K Müller
Journal:  J Comput Aided Mol Des       Date:  1990-12       Impact factor: 3.686

2.  Three-dimensional quantitative structure-activity relationship and comparative molecular field analysis of dipeptide hydroxamic acid Helicobacter pylori urease inhibitors.

Authors:  Hetal Mishra; Abby L Parrill; John S Williamson
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

3.  S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.

Authors:  M Ben Amar; G L'Espérance; R Tawashi
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.